Dr. Kumar's current clinical translational research is intended to improve the detection techniques for diagnostic and predictive biomarkers of type 1 diabetes, and characterization of novel biomarker trends in the at-risk population.

Dr. Goldbogen's research interests include comparative biomechanics, foraging energetics, functional anatomy, and bio-logging technology.

Dr. Lele's research combines numerical simulations with analytical modeling to study fundamental unsteady flow phenomena, turbulence, flow instabilities, and flow-generated sound.

The Suzuki group focuses on the study of novel ground states and functional properties in condensed matter systems synthesized via atomically precise thin film deposition techniques.

Dr. Waymouth's group applies mechanistic principles to develop new concepts in catalysis.

Dr. Nguyen is interested in applying molecular imaging techniques to study stem cell biology and in developing novel cellular and genetic therapy.

Dr. Demirci innovates around point-of-care diagnostics, microfluidics assays, and the development of technology platforms at the convergence of engineering, biology and materials science.

Dr. Engleman's research is directed at understanding the role of the cellular immune system in cancer and other life threatening conditions and in evaluating the potential to manipulate immune cells for the treatment of these diseases.

Dr. Jason Andrews's laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings.

Dr. Shafer's group research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance.